OppenheimerFunds’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
$60.1M Buy
819,956
+3,146
+0.4% +$231K 0.07% 268
2018
Q4
$34.6M Buy
816,810
+291,544
+56% +$12.4M 0.05% 361
2018
Q3
$24.7M Sell
525,266
-3,579
-0.7% -$169K 0.03% 530
2018
Q2
$26.1M Buy
+528,845
New +$26.1M 0.03% 515